Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF)

Author:

Hebestreit Helge1,Kriemler Susi2,Schindler Christian3,Stein Lothar4,Karila Chantal5,Urquhart Don S.6,Orenstein David M.7,Lands Larry C.8,Schaeff Jonathan1,Eber Ernst9,Radtke Thomas2,Eber Ernst,Wagner Marlies,Ellemunter Helmut,Alarie Nancy,Simon Clotilde,Faucou Anne,Mely Laurent,Ravaninjatovo Bruno,Prevotat Anne,Koerner-Rettberg Cordula,Hammermann Jutta,Smaczny Christina,Held Inka,Junge Sibylle,Nitsche Oliver,Fischer Rainald,Große-Onnebrink Jörg,Wesner Anne,Hector Andreas,Hebestreit Alexandra,Benden Christian,Casaulta Carmen,Fischer Reta,Möller Alexander,Hulzebos Erik,Burghard Marcella,Blacklock Sarah,Miller Debbie,Johnstone Zoe,Lowman John D.

Affiliation:

1. Paediatric Department, University Hospitals Würzburg, Würzburg, Germany;

2. Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland;

3. Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland;

4. Institute of Sports Medicine, Hannover Medical School, Hannover, Germany;

5. Service de Pneumologie et Allergologie Pédiatriques, AP-HP Hôpital Necker Enfants Malades, Université Paris Descartes, Paris, France;

6. Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Sick Children, Edinburgh, United Kingdom;

7. Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania;

8. Montreal Children’s Hospital, McGill University Health Centre, Montreal, Quebec, Canada; and

9. Division of Paediatric Pulmonology and Allergology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria

Funder

Mukovizisose e.V.

Swiss Society for Cystic Fibrosis

Cystic Fibrosis Canada

Stiftung Telethon Aktion Schweiz

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Vertex Pharmaceuticals

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3